Carlos Ruiz and performance-enhancing drugs

24 Comments

There are a lot of differing opinions out there, educated and otherwise, on just how much performance-enhancing drugs actually enhance performance. On the one side, there’s suspected users like Barry Bonds and Roger Clemens pulling off incredible feats at advanced ages. On the other, there’s the long list of proven cheaters littered with names of journeymen long forgotten.

Now, though, that long list has suddenly gotten interesting at the end. The last three veteran major leaguers caught cheating were all exceeding expectations in a pretty big way:

– Melky Cabrera, the 2012 All-Star Game MVP, was leading the NL with a .346 average through 113 games when he was suspended. His OPS went from .671 in 2010 to .809 in 2011 to .906 last season.

– Bartolo Colon had a 3.43 ERA in 24 starts for Oakland prior to his suspension. Two years after his career was presumed over due to shoulder problems, he was on his way to his best season since 2005. Had he maintained the 3.43 ERA, it would have been his second-lowest mark in 15 big-league seasons.

– Carlos Ruiz established new career highs in average (.325), homers (16) and RBI (68) as a 33-year-old last season. The homer total was two more than he had the previous two seasons combined. His .540 slugging percentage was almost 150 points higher than his career mark of .393.

Of course, Ruiz, unlike the other two, wasn’t caught with testosterone. And because he was using an amphetamine, not a steroid, he’s getting just a 25-game suspension (Cabrera and Colon received 50 games apiece).

Whether the Adderall deserves any credit for Ruiz’s performance spike is a matter I’ll let others debate. But it’s more ammunition for those who believe that cheaters get an incredible advantage over those who get their results naturally.

Phillies’ Bryce Harper to miss start of season after elbow surgery

Getty Images
2 Comments

PHILADELPHIA – Phillies slugger Bryce Harper will miss the start of the 2023 season after he had reconstructive right elbow surgery.

The operation was performed by Dr. Neal ElAttrache in Los Angeles.

Harper is expected to return to Philadelphia’s lineup as the designated hitter by the All-Star break. He could be back in right field by the end of the season, according to the team.

The 30-year-old Harper suffered a small ulnar collateral ligament tear in his elbow in April. He last played right field at Miami on April 16. He had a platelet-rich plasma injection in May and shifted to designated hitter.

Harper met Nov. 14 with ElAttrache, who determined the tear did not heal on its own, necessitating surgery.

Even with the elbow injury, Harper led the Phillies to their first World Series since 2009, where they lost in six games to Houston. He hit .349 with six homers and 13 RBIs in 17 postseason games.

In late June, Harper suffered a broken thumb when he was hit by a pitch and was sidelined for two months. The two-time NL MVP still hit .286 with 18 homers and 65 RBIs for the season.

Harper left Washington and signed a 13-year, $330 million contract with the Phillies in 2019. A seven-time All-Star, Harper has 285 career home runs.

With Harper out, the Phillies could use Nick Castellanos and Kyle Schwarber at designated hitter. J.T. Realmuto also could serve as the DH when he needs a break from his catching duties.